You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-Bcl-2-Sonrotoclax
Sonrotoclax

Chemical Structure : Sonrotoclax

CAS No.: 2383086-06-2

Sonrotoclax (BGB-11417, BGB11417)

Catalog No.: PC-21675Not For Human Use, Lab Use Only.

Sonrotoclax (BGB-11417) is a potent, selective and second-generation BCL2 inhibitor with IC50 of 0.014 nM and SPR KD value of 0.046 nM, overcomes BCL2 G101V mutation-induced venetoclax resistance.

Packing Price Stock Quantity
1 mg $328 In stock
5 mg $698 In stock
10 mg Get quote
25 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Sonrotoclax (BGB-11417) is a potent, selective and second-generation BCL2 inhibitor with IC50 of 0.014 nM and SPR KD value of 0.046 nM, overcomes BCL2 G101V mutation-induced venetoclax resistance.
Sonrotoclax inhibits the BCL2-BAK interaction with IC50 of 0.014 nM, exhibiting a 14-fold increase in potency compared to venetoclax (Cat#PC-49764).
Sonrotoclax also demonstrates better selectivity than venetoclax for other Bcl-2 family members, particularly BCL-xL (2000-fold), which is related to platelet toxicity and dose-limiting thrombocytopenia.
Sonrotoclax exhibits superior potency compared to venetoclax in different hematological cancer cells and xenograft models.
Sonrotoclax exhibits IC50 of 7.7 nM for BCL2 G101V mutant, RS4;11 cells, venetoclax has IC50 of 170 nM.
Sonrotoclax (50 mg/kg) resulted in rapid tumor regression in in RS4;11 BCL2 G101V xenografts mice (TGI of 106%), but venetoclax (50 mg/kg) exhibited inadequate efficacy (TGI of 61%).
Sonrotoclax also potently inhibits other BCL2 variants, including R129L, A113G, D103Y and V156D mutants (KD values=0.04-2.1 nM).
Sonrotoclax (50 mg/kg) showed robust anti-tumor activity in the KMS-12-PE D103Y xenograft model.

Physicochemical Properties

M.Wt 890.11
Formula C49H59N7O7S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[[4-[[(trans-4-Hydroxy-4-methylcyclohexyl)methyl]amino]-3-nitrophenyl]sulfonyl]-4-[2-[(2S)-2-[2-(1-methylethyl)phenyl]-1-pyrrolidinyl]-7-azaspiro[3.5]non-7-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide

References

1. Liu J, et al. Blood. 2024 Jan 11:blood.2023019706.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: